Regulatory

This week, the influential watchdog organization's senior vice president for government affairs implored the House Committee on Energy and Commerce to increase FDA's authority in the personal care sphere.

Organic sector and Capitol Hill show strong support for rule in final comments.

Congress said to legalize it, and left it to FDA to figure out details. FDA's position: pound sand.

Motion for summary judgment states USDA acted unlawfully in withdrawing livestock standards.

Lawmakers seek a policy of enforcement discretion but that wouldn’t address the underlying problem facing the hemp industry—namely FDA’s position that CBD cannot be marketed in a dietary supplement.

Former Food and Drug Administration Commissioner Scott Gottlieb lays out a pharma-friendly pathway for CBD in a Washington Post op-ed.

The new law is part of a growing movement driven by social enterprise and impact investors seeking out a new relationship to ownership.

The FDA hosted a day-long public meeting on “Responsible Innovation in Dietary Supplements." The meeting was highly anticipated as a sign of how open the FDA is to working with the supplements industry. Attendees offered different takeaways on...

Once thought to be the future of brick-and-mortar retail, cashless stores are now facing legal repercussions on the basis of economic discrimination.